Abstract
Hydrogen sulfide is the newest member of gasotransmitter family. Endogenous production of hydrogen sulfide in brain was first reported in 1996. Since then a great deal of interest has been paid to understand various physiological roles of this molecule, still there are a lot of gaps that need to be addressed. This article provides author’s perspective on research accomplishments in this area briefly, gaps and future opportunities, which may transform the area of medicine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
